Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI takes on the Doctor's note: can machines write clear health advice?

NCT ID NCT06997107

NEW Knowledge-focused Sponsor: Hopital Montfort Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

This study asks whether generative AI can produce patient education messages that match the quality of messages written by human health experts. Researchers generate short and long health messages on various topics using both ChatGPT 4.0 and human experts in primary care or public health. Diverse panels of patients and providers then rate the messages on clarity, understandability, relevance, and usefulness, with attention to how accessible the messages are across different socioeconomic groups. The goal is to learn whether AI can help primary care deliver trusted health information and reduce the burden on strained healthcare teams.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Health messages written by AI (ChatGPT 4.0) compared with messages written by human health experts
What this could lead to
If AI-written messages rate as well as human-written ones, primary care clinics could produce clear patient education faster and at lower cost, which may free up staff time and help reach more patients.
What could go wrong
This is a small study of 56 reviewers, and people rating messages may score them differently than real patients reading them at home. AI messages can also contain errors or miss cultural context, so high ratings would not guarantee safe use in every setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

56 people

The number who actually took part.

Started

Jan 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Content team members: Content team members must have an expertise in primary care, public health, or health communication. The investigators aim to recruit at least two or three members whose mother tongue is French. * Providers' review panel: The investigators will recruit a diverse group of primary care providers. All providers who provide comprehensive care in Canada and will be eligible to participate. They must be proficient in either written English or French. They must be able to consent to participate in this study. * Patients' review panel: The investigators will recruit a diverse group of patients. All must be aged 18 years or older and be proficient in either written English or French. They must be able to consent to participate in this study. Exclusion Criteria: * Content team members, primary care providers, or patients who cannot write (content team members) or read (review panels) in either French or English will be excluded. Primary care providers or patients who do not have an email address, a computer or a cellphone to complete the evaluations on REDCap will also be excluded. The investigators will not include minors or patients who cannot provide informed consent themselves, such as those with advanced dementia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary care patients are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Primary care patients

Contacts and locations

Locations

  • Institut du Savoir Montfort

    Ottawa, Ontario, K1N 0T2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.